Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

By Shariat S.F.   Kim J.   Raptidis G.   Ayala G.E.   Lerner S.P.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1140-1145

Elsevier

Access to resources Recommend Favorite

The Prognostic Importance of E-cadherin and p53 Gene Expression in Transitional Bladder Carcinoma Patients

By Serdar Arisan   Turhan Caskurlu   Soner Guney   Cem Sonmez   Bayram Keles   Damla Buyuktuncer   Erbil Ergenekon  

International Urology and Nephrology, Vol. 37, Iss. 3, 2005-09 ,pp. : 485-492

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors in carcinoma in situ of the urinary bladder

By Gils-Gielen R.J.M.v.   Witjes W.P.J.   Caris C.T.M.   Debruyne F.M.J.   Witjes J.A.   Oosterhof G.O.N.  

Urology, Vol. 45, Iss. 4, 1995-04 ,pp. : 581-586

Elsevier

Access to resources Recommend Favorite

Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients

By Yang Hua  

Surgery Today, Vol. 41, Iss. 6, 2011-06 ,pp. : 810-817

Springer Publishing Company

Access to resources Recommend Favorite

Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults

By Rosser C.J.   Slaton J.W.   Izawa J.I.   Levy L.B.   Dinney C.P.N.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1151-1155

Elsevier

Access to resources Recommend Favorite